Subtle variations in thyroid-stimulating hormone within the normal range: biological mechanisms, microvascular effects, and clinical relevance in euthyroid adults

Objective This review synthesizes the mechanistic pathways linking high-normal thyroid-stimulating hormone levels with low-grade inflammation, microvascular endothelial reactivity, and adipocyte physiology in euthyroid adults. Methods Recent literature investigating physiological thyroid-stimulating hormone fluctuations within the reference interval of zero point four to four point zero milli-international units per liter was synthesized. Evidence from physiological, clinical, and Mendelian randomization studies was analyzed to distinguish direct hormonal effects from secondary metabolic responses. Results Elevated thyroid-stimulating hormone levels in the upper normal range often represent a secondary neuroendocrine response to visceral adiposity and central leptin adaptation rather than primary thyroid failure. At the tissue level, thyroid-stimulating hormone directly interacts with adipocyte receptors to modulate lipogenesis, pre-adipocyte differentiation, and local insulin sensitivity. Concurrently, high-normal levels correlate with subtle markers of microvascular dysfunction and systemic inflammation. Mendelian randomization indicates that while overall adiposity causally increases thyroid-stimulating hormone levels, high-normal levels act primarily as a downstream biomarker of metabolic stress rather than a primary driver of cardiovascular disease. Conclusions High-normal thyroid-stimulating hormone is best understood as an integrated metabolic biomarker rather than a target for hormonal intervention. Recognizing these connections helps clinicians contextualize subtle endocrine variations without altering standard treatment thresholds.

Authors

Institutions

Publication Details

Journal
Acta Marisiensis. Seria Medica
Published
2026-11-19
DOI
https://doi.org/10.62838/amsm-2026-0038
Primary Topic
Thyroid Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Subtle variations in thyroid-stimulating hormone within the normal range: biological mechanisms, microvascular effects, and clinical relevance in euthyroid adults

Lorand Iozsef Ferencz, Oana-Cristina Cinpeanu
Acta Marisiensis. Seria Medica
Thyroid Disorders and Treatments
article

Subtle variations in thyroid-stimulating hormone within the normal range: biological mechanisms, microvascular effects, and clinical relevance in euthyroid adults

Lorand Iozsef Ferencz, Oana-Cristina Cinpeanu
article en

Abstract

Objective This review synthesizes the mechanistic pathways linking high-normal thyroid-stimulating hormone levels with low-grade inflammation, microvascular endothelial reactivity, and adipocyte physiology in euthyroid adults. Methods Recent literature investigating physiological thyroid-stimulating hormone fluctuations within the reference interval of zero point four to four point zero milli-international units per liter was synthesized. Evidence from physiological, clinical, and Mendelian randomization studies was analyzed to distinguish direct hormonal effects from secondary metabolic responses. Results Elevated thyroid-stimulating hormone levels in the upper normal range often represent a secondary neuroendocrine response to visceral adiposity and central leptin adaptation rather than primary thyroid failure. At the tissue level, thyroid-stimulating hormone directly interacts with adipocyte receptors to modulate lipogenesis, pre-adipocyte differentiation, and local insulin sensitivity. Concurrently, high-normal levels correlate with subtle markers of microvascular dysfunction and systemic inflammation. Mendelian randomization indicates that while overall adiposity causally increases thyroid-stimulating hormone levels, high-normal levels act primarily as a downstream biomarker of metabolic stress rather than a primary driver of cardiovascular disease. Conclusions High-normal thyroid-stimulating hormone is best understood as an integrated metabolic biomarker rather than a target for hormonal intervention. Recognizing these connections helps clinicians contextualize subtle endocrine variations without altering standard treatment thresholds.

Acta Marisiensis. Seria Medica
Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș (RO), Spitalul Clinic Judetean de Urgenta Târgu Mureş (RO)
Thyroid Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon